Contact hours available until 8/31/17.

Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online CNE evaluation.

Faculty, Planners and Authors Conflict of Interest Disclosure:
The author, editor, and education director reported no actual or potential conflict of interest in relation to this continuing nursing education article.

Urologic Nursing Editorial Board Statements of Disclosure
Christine Bradway, PhD, CRNP, FAAN, disclosed that she is a Consultant for Direct Supply, Inc. All other Editorial Board members, as well as the Editor, author, and Education Director, reported no actual or potential conflict of interest in relation to this continuing nursing education article.

Commercial Support and Sponsorship:
No commercial support or sponsorship declared.

Accreditation Statement:
Society of Urologic Nurses and Associates is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center''s Commission on Accreditation.

SUNA is a provider approved by the California Board of Registered Nursing, provider number, CEP 5556.

The purpose of this CNE activity is to provide an overview of Peyronie's disease, along with evaluation and advances in treatment therapies. For those wishing to obtain CNE credit, an evaluation follows. After studying the information presented in this article, the nurse will be able to:

Define Peyronie's disease.
Discuss the procedure to evaluate for Peyronie's disease.
Describe current treatment therapies for Peyronie's disease.
Explain advances in treatment therapies for Peyronie's disease.

Jacqueline Pires

Appearances